Acting at the level of the brain, interleukin- (IL-)1βis considered to be one of the most potent downregulators of reproduction processes during immune/inflammatory challenge. IL-1βsuppresses gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus resulting in the inhibition of the luteinizing hormone (LH) release from the anterior pituitary (AP). However, the presence of IL-1βreceptors in the AP suggests the possible direct action of this cytokine on LH secretion. The study was designed to determine the effect of IL-1βon the LH secretion from the AP explants collected from saline and LPS-treated ewes in the follicular phase. It was found that IL-1βsuppressed () GnRH-stimulated LH release and LHβgene expression in AP explants in both groups. However, IL-1βaction was more potent in the explants collected from LPS-treated animals. Pituitaries from LPS-treated animals were characterized by increased () IL-1 type I receptor and decreased () GnRH receptor gene expression level compared to the saline-treated group. IL-1βalso affected the GnRH-R gene expression in explants collected from LPS-treated animals. Our results show that direct action of IL-1βon the pituitary gonadotropes could be one of the reasons of the reproductive processes disorders accompanying an inflammatory state.
The growth hormone (GH) plays a key role in the regulation of metabolic processes in an organism. Determination of the correct structure and functioning of the growth hormone receptor (GHR) allowed for a more detailed research of its post-receptor regulators, which substantially influences its signal transduction. This review is focused on the description of the post-receptor inhibitors of the GHR-JAK2-STAT pathway, which is one of the most important pathways in the transduction of the somatotropic axis signal. The aim of this review is the short characterization of the main post-receptor inhibitors, such as: cytokine-inducible SH2-containing protein (CIS), Suppressors of Cytokine Signaling (SOCS) 1, 2 and 3, sirtuin 1 (SIRT1), protein inhibitors of activated STAT (PIAS) 1, 3 and PIAS4, protein tyrosine phosphatases (PTP) 1B and H1, Src homology 2 (SH2) domain containing protein tyrosine phosphatase (SHP) 1, 2 and signal regulatory protein (SIRP) α1. The equilibrium between these regulators activity and inhibition is of special concern because, as many studies showed, even slight imbalance may disrupt the GH activity causing serious diseases. The regulation of the described inhibitors expression and activity may be a point of interest for pharmaceutical industry.